Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Viggo, Skar"'
Publikováno v:
Gastroenterology Research and Practice, Vol 2017 (2017)
Objectives. Mucosal healing has become the new goal of treatment in ulcerative colitis. Fecal calprotectin has been demonstrated to differentiate between mucosal inflammation and mucosal healing. With this project, we investigated whether a reduction
Externí odkaz:
https://doaj.org/article/a523bdd97ac040b6828e088175ab3d5b
Autor:
Håvard Aanes, Jørgen G. Bramness, Asle W. Medhus, Jørgen Valeur, Steinar Traae Bjørkhaug, Viggo Skar, Sudan Prasad Neupane
Publikováno v:
Alcohol (Fayetteville, N.Y.). 85
Background Alcohol-related morbidity may involve changes in the gut microbiota and immune dysregulation. We have previously demonstrated alterations in gut microbiota composition and functions in patients with alcohol overconsumption, and now aimed t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::21bb17a671ed98074a6f5ce93d30926c
https://pubmed.ncbi.nlm.nih.gov/31610228
https://pubmed.ncbi.nlm.nih.gov/31610228
Autor:
Christine Henriksen, Jørgen Valeur, Steinar Traae Bjørkhaug, Sudan Prasad Neupane, Håvard Aanes, Asle W. Medhus, Viggo Skar, Stine Malvik, Jørgen G. Bramness
Publikováno v:
Gut microbes
Gut Microbes
Gut Microbes
Excessive alcohol intake can alter the gut microbiota, which may underlie the pathophysiology of alcohol-related diseases. We examined gut microbiota composition and functions in patients with alcohol overconsumption for >10 years, compared to a cont
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::148513a936bb3907bc0d7126486d8bf8
https://hdl.handle.net/11250/2633051
https://hdl.handle.net/11250/2633051
Publikováno v:
Scandinavian journal of gastroenterology. 48(10)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::361338e15e5ddb5654d513824120aa10
https://pubmed.ncbi.nlm.nih.gov/22229732
https://pubmed.ncbi.nlm.nih.gov/22229732
Publikováno v:
Gastroenterology Research and Practice
Gastroenterology Research and Practice, Vol 2017 (2017)
Gastroenterology Research and Practice, Vol 2017 (2017)
Objectives. Mucosal healing has become the new goal of treatment in ulcerative colitis. Fecal calprotectin has been demonstrated to differentiate between mucosal inflammation and mucosal healing. With this project, we investigated whether a reduction
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::37f1c688e94f8b2c9487b74eade26ef5
http://hdl.handle.net/10852/63030
http://hdl.handle.net/10852/63030
Publikováno v:
Scandinavian Journal of Gastroenterology. 47:428-434
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::62d66fb2152b52efa2909eab2cd78ac9
https://doi.org/10.3109/00365521.2011.648951
https://doi.org/10.3109/00365521.2011.648951
Publikováno v:
Scandinavian Journal of Gastroenterology. 46:414-419
Objective. Alterations of the small intestinal absorptive surface are a probable cause of d-xylose malabsorption in chronic alcoholism. Delayed gastric emptying, however, may influence the 13C-d-xylose breath test, which is used to study intestinal f
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a86a11a3cf8d9cf37ed04477acf55b12
https://doi.org/10.3109/00365521.2010.536252
https://doi.org/10.3109/00365521.2010.536252
Publikováno v:
Scandinavian Journal of Gastroenterology. 43:166-173
Xylose absorption testing has traditionally involved measurement of serum xylose and/or measurement of excreted xylose in urine. However, by enriching xylose with a 13C- or 14C-isotope, absorption of an oral xylose load will be reflected in the time-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9a01ca474e2db0e9c3334e648a0fd15e
https://doi.org/10.1080/00365520701659118
https://doi.org/10.1080/00365520701659118
Publikováno v:
Scandinavian journal of gastroenterology. 51(5)
Faecal (f-) calprotectin is a biomarker of intestinal inflammation. Previous studies have described intra-individual day-to-day variability of this biomarker in patients with inflammatory bowel disease (IBD) and morning samples have been suggested fo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ffbe07fa4f7bcbbc94b5525c7d387905
https://pubmed.ncbi.nlm.nih.gov/26634305
https://pubmed.ncbi.nlm.nih.gov/26634305
Publikováno v:
Journal of Crohn'scolitis. 9(2)
Background and aims As mucosal healing is the goal of treatment in inflammatory bowel disease, defining a faecal (f-) calprotectin cut-off level for mucosal healing is crucial. Previous studies have presented different cut-off levels. The aim of this
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::133476786401e20912842e480ba466a2
https://pubmed.ncbi.nlm.nih.gov/26040316
https://pubmed.ncbi.nlm.nih.gov/26040316